[Applications and safety of modern antidepressants in patients with liver diseases].

Jul 5, 2007Wiadomosci lekarskie (Warsaw, Poland : 1960)

Use and safety of modern antidepressants in people with liver disease

AI simplified

Psychedelic Science on OpenScience ↗PubMed ↗

Abstract

Safety of SSRIs and related medications was analyzed in patients with depression and liver disease.

The study evaluated various medications including venlafaxine, milnacipran, mirtazapine, nefazodone, and trazodone.
Patients had a diagnosis of depression alongside liver disease.
Findings related to the safety of these medications in this patient population were assessed.

AI simplified

Weekly Psychedelic Science Brief

You found one interesting study. We’ll send the next 7.

Get 7 new psychedelic science papers each week, explained in plain English with direct links to the originals.

what lands in your inbox each week:

📚7 fresh studies
📝plain-language summaries
✅direct links to original studies
🏅top journal indicators
📅weekly delivery
🧘‍♂️always free

Recent issues from the psychedelic science brief

DMT works as well as ketamine for depression in mice—and lasts longer

6 days ago7 studies

Psilocybin therapy performed no better than open-label antidepressants for depression

1 week ago7 studies

Psilocybin beats nicotine patches 40.5% vs 10% for quitting smoking

2 weeks ago7 studies

Magic mushroom metabolite psilocin disrupts 40Hz brain waves in rats' right hemisphere

3 weeks ago7 studies

73% of young adults who use hallucinogens are microdosing them

4 weeks ago7 studies

DMT cut depression scores by 7.35 points in 2 weeks vs placebo

5 weeks ago7 studies

Ketamine cuts suicidal thoughts by 1.23 points vs. sedative in 649 patients

6 weeks ago7 studies

Ketamine beats ECT for suicidal depression, while psychedelics rewire brain myelin in rats

7 weeks ago7 studies

Trip dialogue predicted sobriety — and ketamine works via adenosine, not just NMDA receptors

9 weeks ago7 studies

LSD microdoses boost reward processing in depressed brains — while firefighters face barriers to ketamine PTSD treatment

10 weeks ago7 studies

explore the archive

See more issues from the psychedelic science brief